Regenesys

Regenesys

http://www.regenesys.eu

Email: info@regenesys.eu

+32 16 75 13 56

Gaston Geenslaan 1

3001 Heverlee

BE

Regenesys

Foundation date

17-10-2005

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

ReGenesys BVBA is a wholly-owned subsidiary of Athersys, Inc. (NASDAQ: ATHX), a biotechnology company in Cleveland, Ohio, U.S.A., that is developing MultiStem® cell therapy, a patented, adult-derived, “off-the-shelf” stem cell product initially for disease indications in the neurological, cardiovascular, inflammatory and immune areas.  Athersys has several ongoing clinical trials to evaluate its MultiStem product candidate.

Upcoming events

Latest news

  • Mayne Pharma and Mithra announce TGA approval of Nextstellis® oral contraceptive

    22 hours ago

  • Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

    22 hours ago

  • S-Biomedic announces topline results of a successful clinical study in acne

    Friday November 26th 2021

Jobs